» Articles » PMID: 29425030

EIF2B Mechanisms of Action and Regulation: A Thermodynamic View

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2018 Feb 10
PMID 29425030
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Eukaryotic translation initiation factor 2B (eIF2B) is the guanine nucleotide exchange factor of the GTPase eIF2, which brings the initiator Met-tRNA to the ribosome in the form of the eIF2-GTP·Met-tRNA ternary complex (TC). The activity of eIF2B is inhibited by phosphorylation of its substrate eIF2 by several stress-induced kinases, which triggers the integrated stress response (ISR). The ISR plays a central role in maintaining homeostasis in the cell under various stress conditions, and its dysregulation is a causative factor in the pathology of a number of neurodegenerative disorders. Over the past three decades, virtually every aspect of eIF2B function has been the subject of uncertainty or controversy: from the catalytic mechanism of nucleotide exchange, to whether eIF2B only catalyzes nucleotide exchange on eIF2 or also promotes binding of Met-tRNA to eIF2-GTP to form the TC. Here, we provide the first complete thermodynamic analysis of the process of recycling of eIF2-GDP to the TC. The available evidence leads to the conclusion that eIF2 is channeled from the ribosome (as an eIF5·eIF2-GDP complex) to eIF2B, converted by eIF2B to the TC, which is then channeled back to eIF5 and the ribosome. The system has evolved to be regulated by multiple factors, including post-translational modifications of eIF2, eIF2B, and eIF5, as well as directly by the energy balance in the cell, through the GTP:GDP ratio.

Citing Articles

DNL343 is an investigational CNS penetrant eukaryotic initiation factor 2B activator that prevents and reverses the effects of neurodegeneration caused by the integrated stress response.

Yulyaningsih E, Suh J, Fanok M, Chau R, Solanoy H, Takahashi R Elife. 2024; 12.

PMID: 39287504 PMC: 11407769. DOI: 10.7554/eLife.92173.


eIF2Bβ confers resistance to Turnip mosaic virus by recruiting ALKBH9B to modify viral RNA methylation.

Sha T, Li Z, Xu S, Su T, Shopan J, Jin X Plant Biotechnol J. 2024; 22(11):3205-3217.

PMID: 39229972 PMC: 11501005. DOI: 10.1111/pbi.14442.


To initiate or not to initiate: A critical assessment of eIF2A, eIF2D, and MCT-1·DENR to deliver initiator tRNA to ribosomes.

Grove D, Russell P, Kearse M Wiley Interdiscip Rev RNA. 2024; 15(2):e1833.

PMID: 38433101 PMC: 11260288. DOI: 10.1002/wrna.1833.


Development of novel treatments for amyotrophic lateral sclerosis.

Sun Z, Zhang B, Peng Y Metab Brain Dis. 2023; 39(3):467-482.

PMID: 38078970 DOI: 10.1007/s11011-023-01334-z.


Translation dysregulation in neurodegenerative diseases: a focus on ALS.

Wang S, Sun S Mol Neurodegener. 2023; 18(1):58.

PMID: 37626421 PMC: 10464328. DOI: 10.1186/s13024-023-00642-3.


References
1.
Kimball S, Fabian J, Pavitt G, Hinnebusch A, Jefferson L . Regulation of guanine nucleotide exchange through phosphorylation of eukaryotic initiation factor eIF2alpha. Role of the alpha- and delta-subunits of eiF2b. J Biol Chem. 1998; 273(21):12841-5. DOI: 10.1074/jbc.273.21.12841. View

2.
Hinnebusch A . The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem. 2014; 83:779-812. DOI: 10.1146/annurev-biochem-060713-035802. View

3.
Kapp L, Lorsch J . GTP-dependent recognition of the methionine moiety on initiator tRNA by translation factor eIF2. J Mol Biol. 2003; 335(4):923-36. DOI: 10.1016/j.jmb.2003.11.025. View

4.
Kashiwagi K, Takahashi M, Nishimoto M, Hiyama T, Higo T, Umehara T . Crystal structure of eukaryotic translation initiation factor 2B. Nature. 2016; 531(7592):122-5. DOI: 10.1038/nature16991. View

5.
Rowlands A, Panniers R, HENSHAW E . The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biol Chem. 1988; 263(12):5526-33. View